Evigrade

Hypromellose

AEMPS

Artificial tear, ocular surface lubricant

ATC code: S01XA20(Artificial tears and other indifferent preparations)

Brand names: Tears Naturale, Isopto Tears

Updated · Methodology

Indications

B

Dry eye syndrome

First line

An artificial tear is the first step for dryness and burning in the eyes. The AEMPS ficha técnica frames the indication simply: symptomatic relief of eye irritation and dryness, one drop in the conjunctival sac 3 to 5 times a day, more often if needed. The 2016 Cochrane review of over-the-counter artificial tears showed that this group relieves symptoms but found no convincing differences between formulations – the choice goes by tolerance and convenience. The 2017 TFOS DEWS II report places tear substitutes at the first step of treatment, with lid hygiene, anti-inflammatory drops and meibomian gland work coming later. Two practical points from the ficha: with preservative sensitivity the single-dose form is used, and if symptoms last beyond 7 days or vision drops, an ophthalmologist should look.

ICD-10: H04.1

D

Infectious conjunctivitis

Adjunct

A red eye with discharge is often treated with an artificial tear simply because it is already at home. Hypromellose does not treat infection: it has no pharmacological action at all and only moistens the surface. In viral conjunctivitis that brings relief while the illness clears on its own in one to two weeks, but it does not speed recovery. In bacterial conjunctivitis the antibiotic decision belongs to a doctor, and the ficha técnica warns that other eye medicines are instilled 5 minutes before the artificial tear, otherwise the gel gets in their way. A doctor is needed for eye pain, light sensitivity, reduced vision, injury, and when symptoms last beyond a week. If an artificial tear was offered as conjunctivitis treatment instead of an examination, consider seeking a second opinion from an ophthalmologist.

ICD-10: H10.0 · ICD-11: 9A60.3

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

F

Vision improvement and retinal nutrition marketing

Not recommended

Drops «for better vision» and «to rest the eyes after a computer» are sold as a way to preserve visual acuity. An artificial tear does not do that. Hypromellose holds moisture on the eye surface and nothing more; the AEMPS ficha técnica directly classes it as an indifferent preparation with no pharmacological action. Drops change neither myopia nor age-related long-sightedness nor cataract, and they do not affect myopia progression in children. They can help with screen work, but only with the symptom: eyes dry out because at a monitor people blink half as often. What works there is breaks, blinking and screen setup. If drops were offered as a way to improve or preserve vision, consider seeking a second opinion from an ophthalmologist.

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

Hypromellose is partly methylated and hydroxypropylated cellulose. In a healthy eye the cornea is wetted by mucin produced by the conjunctiva: it settles on the surface and makes it hydrophilic so the tear does not roll off. When mucin is short or the tear evaporates too fast, the film breaks and the surface is exposed. Hypromellose replaces that layer: the solution holds on the cornea, raises tear viscosity and lengthens the time to film break-up. The substance is not absorbed and has no pharmacological action – the AEMPS ficha técnica classes it among indifferent preparations. Hence the reaction profile: every described adverse event is local.

Safety

Contraindications

  • Hypersensitivity to hypromellose or excipients

Serious adverse effects

  • Corneal calcification with phosphate-containing drops in people with a damaged cornea, described very rarely
  • Hypersensitivity reactions to preservatives

Common adverse effects

  • Burning after instillation
  • Blurred vision for a few minutes
  • Sticky eyelids

Pregnancy: can you take Hypromellose?

There is no experience of use in pregnancy, but the product is not absorbed and acts only on the eye surface, so systemic effects are not expected.

Breastfeeding: can you take Hypromellose?

There are no data on use while breastfeeding. Hypromellose has no systemic absorption, so passage into breast milk is not expected.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Hypromellose used for?

Hypromellose is evaluated for the following indications with varying evidence strength: Dry eye syndrome (evidence tier B), Infectious conjunctivitis (evidence tier D), Vision improvement and retinal nutrition marketing (evidence tier F). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Hypromellose?

Common side effects of Hypromellose (≥ 1 in 100): Burning after instillation, Blurred vision for a few minutes, Sticky eyelids. See the Safety section for uncommon and serious reactions.

Is Hypromellose safe during pregnancy?

There is no experience of use in pregnancy, but the product is not absorbed and acts only on the eye surface, so systemic effects are not expected.

Is Hypromellose compatible with breastfeeding?

There are no data on use while breastfeeding. Hypromellose has no systemic absorption, so passage into breast milk is not expected.

Who should not take Hypromellose?

Hypromellose is contraindicated in: Hypersensitivity to hypromellose or excipients. Full list in the Safety section.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Latanoprost, Lutein + zeaxanthin, Tetryzoline, Timolol, Bimatoprost, Carbomer, Travoprost, Brimonidine